Tetrahydroisoquinolines for use as MOR/NOP dual agonists
Abstract:
Disclosed are compounds of formula (I) below or pharmaceutically acceptable salts thereof: in which each of variables R1-R6, L, m, and n is defined herein. Also disclosed are a method for treating an opioid receptor-associated condition with a compound of formula (I) and a pharmaceutical composition containing same.
Public/Granted literature
Information query
Patent Agency Ranking
0/0